Xenetic Biosciences, Inc. (XBIO) Total Return Calculator with Dividends Reinvested

Xenetic Biosciences, Inc.

Popular:

The total return for Xenetic Biosciences, Inc. (XBIO) stock is +1.08% over the past 12 months. So far it's up 30.23% this year. The 5-year total return is -86.98%, meaning $10,000 invested in XBIO stock 5 years ago would be worth $1,302 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in XBIO 1 year ago, it would be worth $10,219 today — you'd have gained $219.

With Dividends Reinvested$10,219+2.19%

Price Only (No DRIP)$10,219+2.19%

Period2025-06-23 → 2026-06-18

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in XBIO

1Y$10,108+$108 (+1.1%)1.1% CAGR

3Y$8,069-$1,931 (-19.3%)-6.9% CAGR

5Y$1,302-$8,698 (-87.0%)-33.5% CAGR

10Y$46-$9,954 (-99.5%)-41.7% CAGR

15Y$46-$9,954 (-99.5%)-30.2% CAGR

20Y$46-$9,954 (-99.5%)-23.6% CAGR

30Y$46-$9,954 (-99.5%)-16.4% CAGR

Xenetic Biosciences, Inc. did not pay dividends during this period. Total return = price return.

Loading XBIO total return...

As of 2026-06-22

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+30.23%	—	+30.23%	—	$13,023
1Y	+1.08%	1.08%	+1.08%	—	$10,108
3Y	-19.31%	-6.90%	-19.31%	—	$8,069
5Y	-86.98%	-33.48%	-86.98%	—	$1,302
10Y	-99.54%	-41.65%	-99.54%	—	$46
15Y	-99.54%	-30.17%	-99.54%	—	$46
20Y	-99.54%	-23.61%	-99.54%	—	$46
30Y	-99.54%	-16.44%	-99.54%	—	$46

Risk & Highlights

Best Year+45.71%2020

Worst Year-92.94%2019

Max Drawdown-80.50%2025-10-08 → 2025-12-17

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+17.67%	+17.67%	—	+0.41%	+17.3pp
2025	-46.42%	-46.42%	—	+16.64%	-63.1pp
2024	+11.76%	+11.76%	—	+24.00%	-12.2pp
2023	+13.11%	+13.11%	—	+24.81%	-11.7pp
2022	-79.20%	-79.20%	—	-19.95%	-59.3pp

XBIO underperformed the S&P 500 by 23.91pp over the past year (+1.08% vs +24.99%).

Loading summary...

XBIO Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
XBIOXenetic Biosciences, Inc.	$5M	-4.4%	+30.2%	+1.1%	—	-19.3%	-87.0%	-99.5%
HALOHalozyme Therapeutics, Inc.	$8.1B	+1.6%	-2.5%	+29.0%	—	+98.3%	+65.5%	+688.4%
ADMAADMA Biologics, Inc.	$1.9B	-0.8%	-53.5%	-54.2%	—	+113.1%	+383.1%	+18.4%
IMUXImmunic, Inc.	$140M	+21.8%	+143.6%	+90.3%	—	-15.0%	-89.1%	-99.5%
AGENAgenus Inc.	$125M	-5.1%	-7.1%	-32.9%	—	-92.0%	-97.1%	-96.4%
CRISCuris, Inc.	$82M	-12.3%	-57.0%	-81.7%	—	-97.5%	-99.7%	-99.7%
PRTAProthena Corporation plc	$468M	-6.9%	-2.9%	+55.3%	—	-87.3%	-82.5%	-78.2%
ALNYAlnylam Pharmaceuticals, Inc.	$37.1B	-2.9%	-30.5%	-11.0%	—	+37.9%	+57.2%	+391.0%
ARWRArrowhead Pharmaceuticals, Inc.	$11.5B	+10.6%	+20.7%	+423.8%	—	+128.7%	-4.5%	+1291.5%
IONSIonis Pharmaceuticals, Inc.	$12.2B	+2.2%	-7.0%	+100.3%	—	+80.5%	+96.1%	+221.7%
AMGNAmgen Inc.	$182.2B	+4.1%	+4.6%	+19.9%	+3.4pp	+59.9%	+59.6%	+171.2%

Compare:XBIO vs HALO XBIO vs ADMA XBIO vs IMUX XBIO vs HALO vs ADMA

About XBIO Dividend Returns

Xenetic Biosciences, Inc. (XBIO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of XBIO over the past year?

Xenetic Biosciences, Inc. (XBIO) delivered a return of 1.08% over the past year. Since XBIO does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in XBIO be worth today?

A $10,000 investment in Xenetic Biosciences, Inc. one year ago would be worth $10,108 today, representing a gain of $108.

Q3Does XBIO pay dividends?

Xenetic Biosciences, Inc. (XBIO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For XBIO, the total return equals the price-only return.

Q4Did XBIO beat the S&P 500?

No, Xenetic Biosciences, Inc. (XBIO) underperformed the S&P 500 by 23.91 percentage points over the past year. XBIO delivered a total return of 1.08%, compared to the S&P 500's 24.99%. This means a passive S&P 500 index fund outperformed XBIO by 23.91pp during this period.

Q5What is XBIO's worst drawdown?

Xenetic Biosciences, Inc. (XBIO) experienced a maximum drawdown of -80.50% over the past year, declining from its peak on 2025-10-08 to its trough on 2025-12-17. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is XBIO's long-term total return over 10, 20, or 30 years?

Here are Xenetic Biosciences, Inc. (XBIO)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.5% (-41.7% CAGR) — $10,000 would have grown to $46. Over 20 years: -99.5% total return (-23.6% CAGR) — $10,000 → $46. Over 30 years: -99.5% total return (-16.4% CAGR) — $10,000 → $46. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was XBIO's best and worst year?

Xenetic Biosciences, Inc.'s best calendar year was 2020 with a total return of 45.7%. Its worst year was 2019 with a total return of -92.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 138.7 percentage points.

How much would $100/month in XBIO be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →